Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate

In the face of COVID-19 pandemic caused by the newly emerged SARS-CoV-2, an inactivated, Vero cell-based, whole virion vaccine candidate has been developed and entered into phase III clinical trials within six months. Biochemical and immunogenic characterization of structural proteins and their post...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Yu, Guo, Jing, Wan, Xin, Zhou, Jin-Ge, Jin, Wei-Ping, Lu, Jia, Wang, Wen-Hui, Yang, An-Na, Liu, Ding Xiang, Shi, Zheng-Li, Yuan, Zhi-Ming, Li, Xin-Guo, Meng, Sheng-Li, Duan, Kai, Wang, Ze-Jun, Yang, Xiao-Ming, Shen, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738289/
https://www.ncbi.nlm.nih.gov/pubmed/33232205
http://dx.doi.org/10.1080/22221751.2020.1855945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738289/
https://www.ncbi.nlm.nih.gov/pubmed/33232205
http://dx.doi.org/10.1080/22221751.2020.1855945

Ejemplares similares